Annual FCF:
-$229.81M-$58.82M(-34.40%)Summary
- As of today, CRNX annual free cash flow is -$229.81 million, with the most recent change of -$58.82 million (-34.40%) on December 31, 2024.
- During the last 3 years, CRNX annual free cash flow has fallen by -$140.79 million (-158.15%).
- CRNX annual free cash flow is now -3961.75% below its all-time high of -$5.66 million, reached on December 31, 2016.
Performance
CRNX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$89.05M+$638.00K(+0.71%)Summary
- As of today, CRNX quarterly free cash flow is -$89.05 million, with the most recent change of +$638.00 thousand (+0.71%) on June 30, 2025.
- Over the past year, CRNX quarterly free cash flow has dropped by -$40.45 million (-83.24%).
- CRNX quarterly free cash flow is now -3695.95% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$305.77M-$40.45M(-15.25%)Summary
- As of today, CRNX TTM free cash flow is -$305.77 million, with the most recent change of -$40.45 million (-15.25%) on June 30, 2025.
- Over the past year, CRNX TTM free cash flow has dropped by -$118.69 million (-63.45%).
- CRNX TTM free cash flow is now -12933.72% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CRNX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -34.4% | -83.2% | -63.5% |
| 3Y3 Years | -158.2% | -211.5% | -236.2% |
| 5Y5 Years | -390.3% | -461.3% | -411.9% |
CRNX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -158.2% | at low | -151.0% | +0.7% | -193.2% | at low |
| 5Y | 5-Year | -390.3% | at low | -553.4% | +0.7% | -411.9% | at low |
| All-Time | All-Time | -3961.8% | at low | -3695.9% | +0.7% | >-9999.0% | at low |
CRNX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$89.05M(+0.7%) | -$305.77M(-15.2%) |
| Mar 2025 | - | -$89.69M(-36.5%) | -$265.32M(-15.4%) |
| Dec 2024 | -$229.81M(-34.4%) | -$65.70M(-7.1%) | -$229.81M(-12.9%) |
| Sep 2024 | - | -$61.32M(-26.2%) | -$203.56M(-8.8%) |
| Jun 2024 | - | -$48.60M(+10.3%) | -$187.08M(-1.4%) |
| Mar 2024 | - | -$54.19M(-37.4%) | -$184.45M(-7.9%) |
| Dec 2023 | -$171.00M(-46.3%) | -$39.45M(+12.0%) | -$171.00M(-2.4%) |
| Sep 2023 | - | -$44.84M(+2.5%) | -$167.03M(-3.5%) |
| Jun 2023 | - | -$45.97M(-12.9%) | -$161.35M(-12.1%) |
| Mar 2023 | - | -$40.73M(-14.8%) | -$143.97M(-23.2%) |
| Dec 2022 | -$116.86M(-31.3%) | -$35.48M(+9.4%) | -$116.86M(-12.0%) |
| Sep 2022 | - | -$39.16M(-37.0%) | -$104.30M(-14.7%) |
| Jun 2022 | - | -$28.59M(-109.8%) | -$90.95M(-10.3%) |
| Mar 2022 | - | -$13.63M(+40.5%) | -$82.47M(+7.4%) |
| Dec 2021 | -$89.02M | -$22.92M(+11.2%) | -$89.02M(-8.5%) |
| Sep 2021 | - | -$25.81M(-28.4%) | -$82.06M(-10.4%) |
| Jun 2021 | - | -$20.11M(+0.4%) | -$74.35M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$20.18M(-26.5%) | -$70.11M(-12.7%) |
| Dec 2020 | -$62.21M(-32.7%) | -$15.96M(+11.9%) | -$62.21M(-4.2%) |
| Sep 2020 | - | -$18.10M(-14.1%) | -$59.73M(-8.1%) |
| Jun 2020 | - | -$15.87M(-29.1%) | -$55.24M(-6.2%) |
| Mar 2020 | - | -$12.29M(+8.8%) | -$52.00M(-10.9%) |
| Dec 2019 | -$46.87M(-128.4%) | -$13.47M(+1.0%) | -$46.87M(-18.1%) |
| Sep 2019 | - | -$13.61M(-7.8%) | -$39.69M(-23.9%) |
| Jun 2019 | - | -$12.62M(-76.1%) | -$32.03M(-32.2%) |
| Mar 2019 | - | -$7.17M(-13.9%) | -$24.22M(-18.0%) |
| Dec 2018 | -$20.52M(-109.7%) | -$6.29M(-5.8%) | -$20.52M(-20.9%) |
| Sep 2018 | - | -$5.94M(-23.3%) | -$16.97M(-25.8%) |
| Jun 2018 | - | -$4.82M(-39.1%) | -$13.49M(-55.6%) |
| Mar 2018 | - | -$3.46M(-26.3%) | -$8.67M(-14.8%) |
| Dec 2017 | -$9.78M(-72.9%) | -$2.74M(-11.4%) | -$7.55M(-57.0%) |
| Sep 2017 | - | -$2.46M(-4.9%) | -$4.81M(-104.9%) |
| Mar 2017 | - | -$2.35M | -$2.35M |
| Dec 2016 | -$5.66M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of CRNX is -$229.81M
What is the all-time high annual free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual free cash flow is -$5.66M
What is Crinetics Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, CRNX annual free cash flow has changed by -$58.82M (-34.40%)
What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of CRNX is -$89.05M
What is the all-time high quarterly free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, CRNX quarterly free cash flow has changed by -$40.45M (-83.24%)
What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of CRNX is -$305.77M
What is the all-time high TTM free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, CRNX TTM free cash flow has changed by -$118.69M (-63.45%)